A high expression of TMPRSS2 was significantly associated with a short overall survival in breast invasive carcinoma (BRCA), sarcoma (SARC), and uveal melanoma (UVM), as well as with a long overall survival in lung adenocarcinoma (LUAD) (Figure 2A–D). Here, TMPRSS2 is linked to invasive breast carcinoma.